-
Kardiologia Polska 2023
Topics: Humans; Adult; Ductus Arteriosus, Patent
PubMed: 37319014
DOI: 10.33963/KP.a2023.0134 -
Small and preterm infants: The shrinking frontier of transcatheter patent ductus arteriosus closure.Catheterization and Cardiovascular... May 2017
Topics: Birth Weight; Cardiac Catheterization; Ductus Arteriosus, Patent; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Prosthesis Design; Septal Occluder Device; Treatment Outcome
PubMed: 28432825
DOI: 10.1002/ccd.27076 -
Early Human Development Nov 1993
Review
Topics: Ductus Arteriosus, Patent; Humans; Indomethacin; Infant, Newborn; Infant, Premature; Prognosis
PubMed: 8293712
DOI: 10.1016/0378-3782(93)90133-f -
Catheterization and Cardiovascular... Jan 2005In 2004, the interventional treatment of patent ductus arteriosus (PDA) is definitive and curative. In current practice, coils are used for smaller PDA, and devices are... (Review)
Review
In 2004, the interventional treatment of patent ductus arteriosus (PDA) is definitive and curative. In current practice, coils are used for smaller PDA, and devices are employed for larger PDA. Developing technologies offer small improvements in control and results, but do not appear to promise major changes in practice. This review summarizes the current and emerging interventional technologies directed at PDA closures.
Topics: Coronary Angiography; Ductus Arteriosus, Patent; Humans; Prostheses and Implants; Prosthesis Design; Treatment Outcome
PubMed: 15619281
DOI: 10.1002/ccd.20243 -
Asian Journal of Surgery Dec 2022
Topics: Humans; Ductus Arteriosus, Patent; Hand; Foot; Upper Extremity; Lower Extremity
PubMed: 35768301
DOI: 10.1016/j.asjsur.2022.06.112 -
The Journal of Perinatal & Neonatal... 2006Care of the preterm infant with a suspected or confirmed diagnosis of patent ductus arteriosus (PDA) is a frequent challenge for the neonatal nurse. Management of term... (Review)
Review
Care of the preterm infant with a suspected or confirmed diagnosis of patent ductus arteriosus (PDA) is a frequent challenge for the neonatal nurse. Management of term infants with cardiac lesions dependent upon a PDA can be even more challenging. It is vital for neonatal nurses to understand the normal cardiovascular and pulmonary changes that occur at birth so they can anticipate pathological processes influencing the clinical course of an infant with a PDA. In addition, knowledge of current and effective treatment approaches is essential to providing optimal care for these vulnerable infants, as well as in guiding their parents. The purpose of this article is to review current information about PDA, including physiology, pathophysiology, pharmacological approaches, surgical considerations, complications and outcomes, parental support, and areas for future research.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Echocardiography; Humans; Indomethacin; Infant, Newborn
PubMed: 17310674
DOI: 10.1097/00005237-200610000-00012 -
Ryoikibetsu Shokogun Shirizu 1996
Review
Topics: Diagnosis, Differential; Ductus Arteriosus, Patent; Humans
PubMed: 9117630
DOI: No ID Found -
Pediatrics Jun 2007The purpose of this work was to determine whether the reported association between neonatal morbidities and a patent ductus arteriosus is because of the left-to-right... (Comparative Study)
Comparative Study
OBJECTIVES
The purpose of this work was to determine whether the reported association between neonatal morbidities and a patent ductus arteriosus is because of the left-to-right patent ductus arteriosus shunt itself, the therapies used to treat it, or the immaturity of the infants who are likely to develop a patent ductus arteriosus.
METHODS
A total of 446 infants (<28 weeks' gestation) were treated with the same patent ductus arteriosus care-oriented protocol, and logistic regression analysis was used to examine the effects of several patent ductus arteriosus-related variables (presence of a symptomatic patent ductus arteriosus, the number of indomethacin doses used, the ductus response to indomethacin, and the use of surgical ligation) on the incidence of retinopathy of prematurity, necrotizing enterocolitis, chronic lung disease, death, and neurodevelopmental impairment.
RESULTS
Most of the predictive effects that the presence of a patent ductus arteriosus and its treatment had on neonatal morbidity could be accounted for by the infants' immature gestation. Use of surgical ligation, however, was significantly associated with the development of chronic lung disease and was independent of immature gestation, other patent ductus arteriosus-related variables, or other perinatal and neonatal risk factors known to be associated with chronic lung disease.
CONCLUSIONS
These findings add to the growing uncertainty about the benefits and risks of surgical ligation during the neonatal period.
Topics: Developmental Disabilities; Ductus Arteriosus, Patent; Female; Follow-Up Studies; Humans; Infant, Newborn; Male; Morbidity; Pregnancy; Risk Factors
PubMed: 17545385
DOI: 10.1542/peds.2006-3124 -
Seminars in Perinatology Jun 2018
Topics: Cardiovascular Surgical Procedures; Ductus Arteriosus; Ductus Arteriosus, Patent; History, 15th Century; History, 20th Century; History, Ancient; Humans; Infant, Newborn; Infant, Premature; Perinatology
PubMed: 29891126
DOI: 10.1053/j.semperi.2018.05.001 -
International Journal of Cardiology Oct 2020
Topics: Ductus Arteriosus, Patent; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Pulmonary Artery; Septal Occluder Device
PubMed: 32891262
DOI: 10.1016/j.ijcard.2020.04.057